167
Participants
Start Date
June 30, 2014
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Oral Tranexamic Acid
patients will receive 1950mg of oral prior to surgery to help reduce blood loss during total joint replacement
Intravenous Tranexamic Acid
Patients will receive 1950mg of intravenous Tranexamic Acid prior to total joint arthroplasty and blood loss or need for transfusion within 24 hours post operative
Rush University Medical Center, Chicago
Rush University Medical Center
OTHER